OSSM-001

N/A

Report date: 2026/04/17 20:02:02

Base Information

Drug NameOSSM-001
Drug Alias NameOssium vBM-MSCChymelisCHYMALISMarrow Derived Mesenchymal Stem Cell TherapyvBM-MSC +[6] 
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derivedCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsFistulaGraft vs Host DiseaseIleal Diseases +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOssium Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesCleveland Clinic
Inactive CompaniesCase Western Reserve UniversityOssium Health Inc
Active IndicationsFistulaIleal Diseases
Inactive IndicationsGraft vs Host DiseaseCrohn DiseaseInflammatory Bowel Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A